by Marina Festinese | Sep 15, 2022 | Executive board members
Coming soon!
by wp_3863239 | Feb 9, 2019 | Executive board members
Director of Research at INSERM Research Unit in Nancy, France: INSERM UMR U1122; IGE-PCV (Interactions Géne-Environement en Physiopathologie Cardio-Vasculaire) at the University of Lorraine and of a BRC (Biological Resources Center), the BRC IGE-PCV. Sofia Siest’s...
by wp_3863239 | Feb 9, 2019 | Executive board members
UCB Biopharma Genetics Lead, Director Associate, Professor Associate Genetics, Data & Translational Sciences, Early Solutions Leading expert of Pharmacogenetics in drug discovery. Identification and validation of genetically supported drug targets focusing on...
by wp_3863239 | Feb 9, 2019 | Executive board members
University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia Full Professor of Clinical Biochemistry, PI in genetics of complex disorders Full professor of Clinical Biochemistry, coordinator of PhD program of Clinical Biochemistry at University of Ljubljana and...
by wp_3863239 | Feb 9, 2019 | Executive board members
Thermo Fisher Scientific Associate Director, Business Development Genetic Sciences Division Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our...
by wp_3863239 | Feb 9, 2019 | Executive board members
Dr. Adrián LLerena Ph.D. is the Director of the Clinical Research Center in the University Hospital in Badajoz Spain. He is also professor of Pharmacology and Clinical Pharmacology in the Medical School of the University of Extremadura, between 1989-1993 he did his...
